Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-068922

Chief Executive Officer bought 1,740 shares at $0.88 ($1,531)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sullivan Eddie Joe Chief Executive Officer 2023-12-07 Purchase +1,740 $0.88 $1,531 5,232,304 D
Open-market purchases · 1,740 sh · avg $0.88 · $1,531
Loading xslF345X05/ownership.xml…